![Michael Morrissey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Morrissey
Chief Executive Officer at
EXELIXIS, INC.
Net worth: 171 M $ as of 2026-05-30
Profile
Currently, Michael M. Morrissey occupies the position of President, Chief Executive Officer & Director at Exelixis, Inc. Dr. Morrissey is also on the board of XWPharma Ltd. In his past career Dr. Morrissey occupied the position of Senior Scientist at Ciba-Geigy Corp. and Vice President-Discovery Research at Berlex Biosciences. Michael M. Morrissey received a doctorate from Harvard University and an undergraduate degree from the University of Wisconsin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EXELIXIS, INC. 1.35% | 2026-05-17 | 3,384,063 ( 1.35% ) | 171 M $ | 2026-05-30 |
| 2026-05-20 | 0 ( -.--% ) | - $ | 2026-05-30 |
Michael Morrissey active positions
| Companies | Position | Start |
|---|---|---|
| EXELIXIS, INC. | Chief Executive Officer | 2010-07-21 |
| VERA THERAPEUTICS, INC. | Chairman | 2022-05-23 |
Former positions of Michael Morrissey
| Companies | Position | End |
|---|---|---|
XWPharma Ltd.
 XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Develops drug products for neurological disorders | Director/Board Member | 2023-03-31 |
CERo Therapeutics, Inc.
 CERo Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of engineered T-cell therapeutics for the treatment of cancer | Director/Board Member | 2022-10-31 |
Berlex Biosciences | Corporate Officer/Principal | 1999-12-31 |
Ciba-Geigy Corp.
 Ciba-Geigy Corp. Medical SpecialtiesHealth Technology Manufactures physician and surgical equipment | Chief Tech/Sci/R&D Officer | 1990-12-31 |
Training of Michael Morrissey
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Ciba-Geigy Corp.
Ciba-Geigy Corp. Medical SpecialtiesHealth Technology Manufactures physician and surgical equipment | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Berlex Biosciences | |
XWPharma Ltd.
XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Develops drug products for neurological disorders | Health Technology |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of engineered T-cell therapeutics for the treatment of cancer | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Michael Morrissey
